Subnormal retinal oxygenation response precedes diabetic-like retinopathy

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 9, 1999, Pages 2100-2105

  Berkowitz, Bruce A ^a,b   Kowluru, Renu A ^c   Frank, Robert N ^b   Kern, Timothy S ^d   Hohman, Thomas C ^e   Prakash, Manvi ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; GALACTOSEMIA; MORPHOMETRICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TENSION; PRIORITY JOURNAL; RAT; TISSUE OXYGENATION;

ANIMALS; BLOOD GLUCOSE; CARBON DIOXIDE; DIABETIC RETINOPATHY; FRUCTOSE; GALACTITOL; GALACTOSE; GALACTOSEMIAS; GLUCOSE; INOSITOL; MAGNETIC RESONANCE IMAGING; OXYGEN; PARTIAL PRESSURE; RATS; RETINA; SORBITOL;

EID: 0032820483     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Grunwald JE, Bursell S. Hemodynamic changes as early markers of diabetic retinopathy. Curr Opinion Endo Diabetes. 1996;3:298-306.
2. Harris A, Ciulla TA, Sung Chung H, et al. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol. 1998;116:1491-1495.
3. Tilton RG, Weigel C, Eades D, et al. Increased ocular blood flow and 125 I-albumin permeation in galactose-fed rats: inhibition by sorbinil. Invest Ophthalmol Vis Sci. 1988;29:861-868.
4. Berkowitz BA. Adult and newborn rat inner retinal oxygenation during carbogen and 100% oxygen breathing. Invest Ophthalmol Vis Sci. 1996;37:2089-2098.
5. Berkowitz BA, Wilson CA. Quantitative mapping of ocular oxygenation using magnetic resonance imaging. Magn Reson Med. 1995; 33:579-581.
6. Berkowitz BA. Role of dissolved plasma oxygen in hyperoxia-induced contrast. Magn Reson Imaging. 1997;15:123-126.
7. Berkowitz BA, Penn JS. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1998;39:840-845.
8. Frank RN, Keirn RJ, Kennedy A, et al. Galactose-induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest Ophthalmol Vis Sci 1983;24:1519-1524.
9. Engerman RL, Kern TS. Retinopathy in animal models of diabetes. Diabetes Metab Rev. 1995;11:109-120.
10. Kern TS, Engerman RL. Galactose-induced retinal microangiopathy in rats. Invest Ophthalmol Vis Sci. 1995;36:490-496.
11. Robison WG Jr, Laver NM, Lou MF. The role of aldose reductase in diabetic retinopathy: prevention and intervention studies. Prog Retinal Eye Res. 1995;14:593-640.
12. Aisaka K, Kihara T, Koike M, et al. Effect of yohimbine on urethane-induced hyperglycemia in rats. Jpn J Pharmacol. 1989;49: 523-527.
13. Frank RN, Amin R, Kennedy A, et al. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol. 1997;115:1036-1047.
14. Kern TS, Engerman RL. Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res. 1995;60:545-549.
15. Kowluru RA, Jirousek MR, Stramm LE, et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. Diabetes. 1998;47:464-469.
16. Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with no proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38:36-47.
17. Lutty GA, McLeod DS, Merges C, et al., Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996;114:971-977.
18. Linsenmeier RA, Braun RD, McRipley MA, et al. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998;39:1647-1657.